Tranzyme Pharma
Home
Contact Us
Careers
News
About Us
Products / Pipeline
Our Technology
Partnering
Investors
Resources/Links
Publications & Posters
Title
Date
Type
Size
Tranzyme Pharma, Developing a New Drug for Treatment of Diabetic Gastroparesis
ASweetLife 2012
N/A
TZP-102 Ghrelin Agonist Improves Symptoms of Gastroparesis in Both Type 1 and Type 2 Diabetic Patients: a 28-Day Treatment Study Data
Neurodiab 2011
400.9 KB
TZP-102, Ghrelin Agonist Phase 2 Data: The Improvement in Symptoms of Gastroparesis (Nausea, Early Satiety, Bloating and Abdominal Pain) Significantly Correlated With Patient Rating of Overall Treatment Effect
DDW 2011
170.3 KB
Ghrelin Agonist TZP-101 (Ulimorelin) Accelerates GI Recovery Independent of Opioid Use and Surgery Type
World Journal of Surgery 2011
286.1 KB
TZP-101 (Ghrelin Agonist) Effects in Diabetic Patients with Severe Nausea/Vomiting due to Gastroparesis (GP): Phase 2 Subset Analysis
ADA 2010
158.6 KB
Orally Administered Ghrelin Agonist TZP-102 Decreases Overall Severity of Symptoms of Diabetic Gastroparesis
ACG 2010
920.6 KB
TZP-101 Phase 2 POI Covariate Analysis Poster
ASCRS 2010
291.2 KB
Ghrelin agonist TZP-101 Improves Symptoms and Gastric Emptying in Diabetic Patients with Gastroparesis
ACG 2009
121.7 KB
From Libraries of Small Molecule Macrocycles to Drugs
DDC 2009
348.1 KB
The Ghrelin Agonist TZP-101 for Management of POI After Partial Colectomy
ASCRS 2009
129.3 KB
Ghrelin Agonist (TZP-101) Effects on Severe Symptomatic Diabetic Gastroparesis
ADA 2008
169.2 KB
The motilin receptor antagonist TZP-201 is highly effective in the control of irinotecan induced diarrhea in beagle dogs
AACR 2007
115.5 KB
Ghrelin Agonist (TZP-101) Gastroprokinetic Action in Diabetic Patients with Gastroparesis: A Pilot Study
ADA 2007
1.6 MB
Ghrelin Agonist (TZP-101): Safety, Pharmacokinetics and Pharmacodynamics: A Multi-Dose Evaluation in Healthy Volunteers
AMS 2007
1.2 MB
Pharmacological Demarcation of the Central Effects of Ghrelin on Growth Hormone Release and Food Intake with a Novel Ghrelin Receptor Agonist
ENDO 2007
200.5 KB
= add file to Briefcase
Investors
Investor Relations Home
News
Events & Presentations
Publications & Posters
Corporate Governance
Management
Board of Directors
Committee Composition
Financial Information
SEC Filings
Annual Report and Proxy
Quarterly Results
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Ownership Profile
Investor FAQs
Contact Us
Shareholder Tools
Share this on:
delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz
What is this?